Dogwood Therapeutics, Inc. (DWTX) Balance Sheet
DWTX balance sheet, 2025
December 31, 2025 · U.S. dollars$90.2M assets = $15.3M liabilities + $74.9M equity
Both columns are drawn to the same scale: what DWTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
DWTX financial health
Descriptive bands, not a rating. Fiscal 2025.
DWTX balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $65,9352018 | $90.2M2025 | +180.5%/yr | |
| Total liabilities | $1.3M2018 | $15.3M2025 | +41.8%/yr | |
| Shareholders’ equity | −$1.3M2018 | $74.9M2025 | — | |
| Cash & short-term investments | $30,0262018 | $6.5M2025 | +115.7%/yr | |
| Total debt | $3.6M2019 | $162,6042025 | −40.4%/yr | |
| Net cash (debt) | −$3.3M2019 | $6.4M2025 | +$9.7M | |
| Working capital | −$1.3M2018 | $5.4M2025 | +$6.7M | |
| Current ratio | 0.032018 | 2.762025 | +2.72 | |
| Debt / equity | 0.242024 | 0.002025 | −0.24 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
DWTX assets
DWTX liabilities and equity
DWTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
DWTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $6.5M | $14.8M | $3.3M | $7.0M | $14.0M | $29.8M | $309,384 | $30,026 |
| Cash & equivalents | $6.5M | $14.8M | $3.3M | $7.0M | $14.0M | $29.8M | $309,384 | $30,026 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $324 | $785 | $334 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.9M | $1.7M | $848,496 | $1.3M | $1.8M | $1.7M | $5,731 | $12,038 |
| Total current assets | $8.4M | $16.5M | $4.2M | $8.4M | $15.8M | $31.5M | $315,900 | $42,398 |
| Property, plant & equipment (net) | $194,931 | $222,648 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $81.4M | $77.5M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $158,956 | $18,133 | $0 | $0 | $0 | $0 | $0 | $23,537 |
| Total assets | $90.2M | $94.3M | $4.2M | $8.4M | $15.8M | $31.5M | $315,900 | $65,935 |
| Liabilities | ||||||||
| Accounts payable | $760,945 | $1.2M | $111,913 | $573,164 | $353,863 | $368,905 | $35,421 | $145,656 |
| Short-term debt | $56,841 | $49,696 | — | — | — | — | — | — |
| Total current liabilities | $3.1M | $3.2M | $358,548 | $1.0M | $1.3M | $1.5M | $1.6M | $1.3M |
| Long-term debt | $0 | $15.4M | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $162,604 | $204,581 | $0 | — | — | — | — | — |
| Other long-term liabilities | $12.2M | $11.5M | $0 | $0 | $0 | $0 | $3.6M | $0 |
| Total liabilities | $15.3M | $30.0M | $358,548 | $1.0M | $1.3M | $1.5M | $5.3M | $1.3M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $2,974 | $133 | $77 | $1,833 | $833 | $830 | $12.6M | $12.6M |
| Retained earnings (deficit) | −$108.1M | −$73.8M | −$61.5M | −$56.2M | −$43.9M | −$28.0M | −$17.6M | −$15.1M |
| Accumulated other comprehensive income | −$587,039 | −$3.9M | — | — | — | — | — | — |
| Total shareholders' equity | $74.9M | $64.3M | $3.8M | $7.3M | $14.5M | $29.9M | −$4.9M | −$1.3M |
| Key figures | ||||||||
| Total debt | $162,604 | $15.6M | — | — | — | — | $3.6M | — |
| Net cash (debt) | $6.4M | −$737,709 | — | — | — | — | −$3.3M | — |
| Working capital | $5.4M | $13.4M | $3.8M | $7.3M | $14.5M | $29.9M | −$1.3M | −$1.3M |
| Tangible book value | −$6.5M | −$13.2M | $3.8M | $7.3M | $14.5M | $29.9M | −$4.9M | −$1.3M |
| Book value per share | $9.11 | — | — | — | — | — | — | — |
| Shares outstanding | 8.2M | — | — | — | — | — | — | — |
| Current ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 | 20.55 | 0.19 | 0.03 |
| Quick ratio | 2.13 | 4.67 | 9.25 | 6.74 | 10.98 | 19.45 | 0.19 | 0.02 |
| Debt / equity | 0.00 | 0.24 | — | — | — | — | — | — |
| Equity / assets | 83.1% | 68.2% | 91.4% | 87.5% | 91.9% | 95.1% | −1,564.6% | −1,911.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $9.6M | $13.2M | $6.5M | $10.1M | $13.4M | $17.5M | $14.8M | $2.0M | $3.0M | $2.4M | $3.3M | $4.8M |
| Cash & equivalents | $9.6M | $13.2M | $6.5M | $10.1M | $13.4M | $17.5M | $14.8M | $2.0M | $3.0M | $2.4M | $3.3M | $4.8M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.4M | $1.8M | $1.9M | $1.5M | $1.3M | $1.6M | $1.7M | $243,430 | $615,706 | $845,079 | $848,496 | $462,788 |
| Total current assets | $11.0M | $15.0M | $8.4M | $11.7M | $14.7M | $19.2M | $16.5M | $2.3M | $3.6M | $3.2M | $4.2M | $5.2M |
| Property, plant & equipment (net) | $142,569 | $159,295 | $194,931 | $189,301 | $207,143 | $209,658 | $222,648 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $69.3M | $80.0M | $81.4M | $80.1M | $81.8M | $89.4M | $77.5M | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $18,362 | $18,719 | $158,956 | $18,743 | $19,125 | $0 | $18,133 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $80.5M | $95.2M | $90.2M | $92.0M | $96.7M | $97.0M | $94.3M | $2.3M | $3.6M | $3.2M | $4.2M | $5.2M |
| Liabilities | ||||||||||||
| Accounts payable | $411,516 | $144,400 | $760,945 | $584,602 | $498,118 | $1.2M | $1.2M | $454,962 | $217,762 | $196,759 | $111,913 | $205,369 |
| Short-term debt | $57,645 | $57,314 | $56,841 | $54,566 | $54,496 | $50,719 | $49,696 | — | — | — | — | — |
| Deferred revenue | $9,390 | $9,573 | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | $2.8M | $2.6M | $3.1M | $2.6M | $1.9M | $2.6M | $3.2M | $1.3M | $500,076 | $570,083 | $358,548 | $487,144 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $15.4M | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $127,208 | $144,930 | $162,604 | $174,778 | $186,990 | $191,244 | $204,581 | — | — | — | $0 | — |
| Other long-term liabilities | $9.3M | $12.0M | $12.2M | $12.0M | $12.3M | $87.3M | $11.5M | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $12.1M | $14.6M | $15.3M | $14.6M | $14.2M | $89.9M | $30.0M | $1.3M | $500,076 | $570,083 | $358,548 | $487,144 |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,363 | $3,340 | $2,974 | $229 | $191 | $191 | $133 | $111 | $2,776 | $1,926 | $77 | $1,926 |
| Retained earnings (deficit) | −$124.6M | −$113.1M | −$108.1M | −$104.3M | −$88.6M | −$84.7M | −$73.8M | −$66.1M | −$63.8M | −$62.8M | −$61.5M | −$60.4M |
| Accumulated other comprehensive income | −$3.0M | −$1.7M | −$587,039 | −$1.6M | −$267,289 | −$3.8M | −$3.9M | — | — | — | — | — |
| Total shareholders' equity | $68.4M | $80.6M | $74.9M | $77.4M | $82.5M | $7.1M | $64.3M | $949,431 | $3.1M | $2.7M | $3.8M | $4.8M |
| Key figures | ||||||||||||
| Total debt | $127,208 | $144,930 | $162,604 | $174,778 | $186,990 | $75.9M | $15.6M | — | — | — | — | — |
| Net cash (debt) | $9.5M | $13.1M | $6.4M | $10.0M | $13.2M | −$58.3M | −$737,709 | — | — | — | — | — |
| Working capital | $8.2M | $12.4M | $5.4M | $9.1M | $12.8M | $16.6M | $13.4M | $949,431 | $3.1M | $2.7M | $3.8M | $4.8M |
| Tangible book value | −$942,536 | $597,633 | −$6.5M | −$2.7M | $778,658 | −$82.3M | −$13.2M | $949,431 | $3.1M | $2.7M | $3.8M | $4.8M |
| Book value per share | $2.00 | $2.40 | $5.16 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 34.1M | 33.5M | 14.5M | — | — | — | — | — | — | — | — | — |
| Current ratio | 3.89 | 5.86 | 2.76 | 4.49 | 7.80 | 7.43 | 5.21 | 1.71 | 7.27 | 5.66 | 11.62 | 10.77 |
| Quick ratio | 3.39 | 5.17 | 2.13 | 3.90 | 7.11 | 6.80 | 4.67 | 1.53 | 6.04 | 4.17 | 9.25 | 9.82 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.70 | 0.24 | — | — | — | — | — |
| Equity / assets | 84.9% | 84.7% | 83.1% | 84.1% | 85.4% | 7.3% | 68.2% | 41.6% | 86.2% | 82.3% | 91.4% | 90.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.
DWTX financial position
At the end of fiscal 2025 (December 31, 2025), Dogwood Therapeutics had total assets of $90.2 million (down 4.4% from a year earlier), total liabilities of $15.3 million and shareholders' equity of $74.9 million. It held $6.5 million in cash and short-term investments against $0.2 million of debt, a net cash position of $6.4 million. Its current ratio was 2.76. In the latest quarter (ended June 30, 2026) total assets were $80.5 million and equity $68.4 million.
Related: DWTX income statement, DWTX cash flow statement, DWTX key metrics. See the DWTX stock overview for the latest quote and news.
DWTX balance sheet FAQ
What are Dogwood Therapeutics's total assets?
Dogwood Therapeutics reported total assets of $90.2 million at the end of fiscal 2025 (December 31, 2025), compared with $94.3 million a year earlier.
How much debt does Dogwood Therapeutics have?
Dogwood Therapeutics had $0.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.
How much cash does Dogwood Therapeutics have?
Dogwood Therapeutics held $6.5 million in cash and short-term investments at the end of fiscal 2025; with $0.2 million of debt that is net cash of $6.4 million.
What is Dogwood Therapeutics's book value?
Dogwood Therapeutics's shareholders' equity (book value) was $74.9 million at the end of fiscal 2025, or $9.11 per share.
What is Dogwood Therapeutics's current ratio?
Dogwood Therapeutics had current assets of $8.4 million and current liabilities of $3.1 million, a current ratio of 2.76 (it can cover its short-term obligations).
How much goodwill does Dogwood Therapeutics have?
Dogwood Therapeutics carried $81.4 million of goodwill and intangible assets, 90.3% of total assets, at the end of fiscal 2025.